Kaposi Sarcoma Tumor Emergence After Third AstraZeneca Jab---Researchers Want to Understand the Connection

Scientists from medical institutions in Mexico and Quebec, Canada investigate the presentation of Kaposi Sarcoma post COVID-19 vaccination—is the incidence a “mere coincidence or something more?”  Represented by Arely Gissell Ramirez Cibrian with the Mexican Institute of Social Security and colleagues the team writes up a case report published in Cureus. They found a clear case of Kaposi sarcoma (KS) just weeks after the patient received their third AstraZeneca jab. Most certainly a temporal relationship, the authors ponder the mechanisms behind the emergence of what looks to be a vaccine-induced cancerous tumor.

Investigating a distinctive occurrence of what the colleagues describe as “classic Kaposi sarcoma (KS) in an individual of Latin origin,” apparently the cancerous outbreak emerges a mere seven days after the third dose of the AstraZeneca-Oxford vaccine called ChAdOx1 nCoV-19.